Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is an open-label, randomized, 2-way crossover, monocentric controlled study in patients (≥ 16 years old) with phenylketonuria (PKU). The comparison will be between the test product (PKU GOLIKE, a prolonged-release amino-acids (AAs) mixture) and standard of care.
Epistemonikos ID: bfbfe64bb65292c4dbd3061bc4ffa3340cfbc5ba
First added on: May 14, 2024